Drugmaker Glenmark Pharmaceuticals Ltd on Tuesday (December 16) said its wholly owned subsidiary Glenmark Specialty S.A. (GSSA) has entered into an exclusive license, collaboration...
Glenmark Pharmaceuticals Inc., USA has announced that it will launch Leucovorin Calcium for Injection USP, 350 mg per single dose vial, in December 2025.Leucovorin...
Cosmo Pharmaceuticals and India’s Glenmark Pharmaceuticals said on Tuesday the European Commission has granted marketing authorisation for Winlevi (clascoterone 10 mg/g cream), clearing the...